Nov 12, 2018 - World

Jerome Corsi, formerly of InfoWars, expects to be indicted by Mueller investigation

Jerome Corsi, a political commentator who was recently subpoenaed to testify in Robert Mueller’s Russia investigation — told ABC News on Monday that he’s expecting an indictment from the special counsel soon.

“I don’t know what they’re going to charge me with. … I think my only crime was that I support Donald Trump. That's my crime, and now I'm going to go to prison for the rest of my life for cooperating with them.”

Details: Corsi was a prominent figure behind the birther conspiracy, which falsely claimed President Obama was born outside the U.S. He has connections to former Trump adviser Roger Stone Jr.

Go deeper

Axios
Updated 56 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Politics: Chris Christie: Wear a mask "or you may regret it — as I did" — Senate Democrats block vote on McConnell's targeted relief bill.
  2. Business: New state unemployment filings fall.
  3. Economy: Why the stimulus delay isn't a crisis (yet).
  4. Health: FDA approves Gilead's remdesivir as a coronavirus treatment — How the pandemic might end — Many U.S. deaths were avoidable.
  5. Education: Boston and Chicago send students back home for online learning.
  6. World: Spain and France exceed 1 million cases.
Go deeper (1 min. read)Arrow
Orion Rummler
1 hour ago - Technology

FBI: Russian hacking group stole data after targeting local governments

FBI Headquarters. Photo: Mark Wilson/Getty Images

Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.

Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.

Go deeper (1 min. read)Arrow
Marisa Fernandez
2 hours ago - Health

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.

Go deeper (1 min. read)Arrow